Retreatment of patients with chronic hepatitis CSHIFFMAN, Mitchell L.Hepatology (Baltimore, Md.). 2002, Vol 36, Num 5, pp S128-S134, issn 0270-9139, SUP1Conference Paper

Impact of Peginterferon Maintenance Therapy on the Risk of Developing Hepatocellular Carcinoma in Patients with Chronic Hepatitis C VirusSHIFFMAN, Mitchell L.Oncology. 2010, Vol 78, pp 11-16, issn 0030-2414, 6 p., SUP1Conference Paper

Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytesSHIFFMAN, Mitchell L; VERBEKE, Scott B; KIMBALL, Pamela M et al.Antiviral research. 2000, Vol 48, Num 2, pp 91-99, issn 0166-3542Article

Response to Hepatitis A and B Vaccine Alone or in Combination in Patients with Chronic Hepatitis C Virus and Advanced FibrosisSETH KRAMER, Erik; HOFMANN, Charlotte; SMITH, Paula G et al.Digestive diseases and sciences. 2009, Vol 54, Num 9, pp 2016-2025, issn 0163-2116, 10 p.Article

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment OptionsJACOBSON, Ira M; GORDON, Stuart C; SCHIFF, Eugene et al.The New England journal of medicine. 2013, Vol 368, Num 20, pp 1867-1877, issn 0028-4793, 11 p.Article

Retreatment with Telaprevir Combination Therapy in Hepatitis C Patients with Well-Characterized Prior Treatment ResponseMUIR, Andrew J; POORDAD, Fred F; DUSHEIKO, Geoffrey et al.Hepatology (Baltimore, Md.). 2011, Vol 54, Num 5, pp 1538-1546, issn 0270-9139, 9 p.Article

Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves OutcomeSHERMAN, Morris; STRAVITZ, Richard Todd; CITES, Ho-Chong S et al.The American journal of medicine. 2008, Vol 121, Num 2, issn 0002-9343, 89-90, 119-126 [10 p.]Article

Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis CPOCKROS, Paul J; SCHIFF, Eugene R; SHAPIRO, David A et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 2, pp 324-329, issn 0270-9139, 6 p.Article

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonrespondersLEE, William M; DIENSTAG, Jules L; MORISHIMA, Chihiro et al.Controlled clinical trials. 2004, Vol 25, Num 5, pp 472-492, issn 0197-2456, 21 p.Article

Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndromeSANYAL, Arun J; CONTOS, Melissa J; STERLING, Richard K et al.The American journal of gastroenterology. 2003, Vol 98, Num 9, pp 2064-2071, issn 0002-9270, 8 p.Article

Treatment of chronic hepatitis C in patients who failed interferon monotherapy : Effects of higher doses of interferon and ribavirin combination therapySHIFFMAN, Mitchell L; HOFMANN, Charlotte M; GABBAY, Joubin et al.The American journal of gastroenterology. 2000, Vol 95, Num 10, pp 2928-2935, issn 0002-9270Article

Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels : Comparison of hepatic histology and response to interferon therapySHIFFMAN, Mitchell L; STEWART, Charmaine A; HOFMANN, Charlotte M et al.The Journal of infectious diseases. 2000, Vol 182, Num 6, pp 1595-1601, issn 0022-1899Article

Quantitative Liver Function Tests Improve the Prediction of Clinical Outcomes in Chronic Hepatitis C: Results From the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis TrialEVERSON, Gregory T; SHIFFMAN, Mitchell L; HOEFS, John C et al.Hepatology (Baltimore, Md.). 2012, Vol 55, Num 4, pp 1019-1029, issn 0270-9139, 11 p.Article

Identifying Hepatitis C Virus Genotype 2/3 Patients Who Can Receive a 16-Week Abbreviated Course of Peginterferon Alfa-2a (40KD) Plus RibavirinDIAGO, Moises; SHIFFMAN, Mitchell L; BRONOWICKI, Jean-Pierre et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 6, pp 1897-1903, issn 0270-9139, 7 p.Article

Virologic Response Rates of Weight-Based Taribavirin Versus Ribavirin in Treatment-Naive Patients with Genotype 1 Chronic Hepatitis CPOORDAD, Fred; LAWITZ, Eric; SHIFFMAN, Mitchell L et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 4, pp 1208-1215, issn 0270-9139, 8 p.Article

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonDI BISCEGLIE, Adrian M; SHIFFMAN, Mitchell L; GHANY, Marc G et al.The New England journal of medicine. 2008, Vol 359, Num 23, pp 2429-2441, issn 0028-4793, 13 p.Article

Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon α-2a (40 kDa) plus ribavirin : Impact on health-related quality of lifeARORA, Sanjeev; O'BRIEN, Christopher; WINTFELD, Neil et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 2, pp 406-412, issn 0815-9319, 7 p.Article

Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis CPRATI, Daniele; SHIFFMAN, Mitchell L; ZEUZEM, Stefan et al.Journal of hepatology. 2006, Vol 44, Num 4, pp 679-685, issn 0168-8278, 7 p.Article

Comparison of three commercially available assays for HCV RNA using the international unit standard: Implications for management of patients with chronic hepatitis C virus infection in clinical practiceSHIFFMAN, Mitchell L; FERREIRA-GONZALEZ, Andrea; REDDY, K. Rajender et al.The American journal of gastroenterology. 2003, Vol 98, Num 5, pp 1159-1166, issn 0002-9270, 8 p.Article

Intensive interferon therapy does not increase virological response rates in African Americans with chronic hepatitis CTHEODORE, Dickens; SHIFFMAN, Mitchell L; NOLTE, Frederick S et al.Digestive diseases and sciences. 2003, Vol 48, Num 1, pp 140-145, issn 0163-2116, 6 p.Article

Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapySARRAZIN, Christoph; SHIFFMAN, Mitchell L; HADZIYANNIS, Stephanos J et al.Journal of hepatology. 2010, Vol 52, Num 6, pp 832-838, issn 0168-8278, 7 p.Article

Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Hepatitis C Patients with Advanced Fibrosis and CirrhosisBRUNO, Savino; SHIFFMAN, Mitchell L; ROBERTS, Stuart K et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 2, pp 388-397, issn 0270-9139, 10 p.Article

Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3SHIFFMAN, Mitchell L; MIHAS, Anastasios A; MILLWALA, Farida et al.The American journal of gastroenterology. 2007, Vol 102, Num 4, pp 761-766, issn 0002-9270, 6 p.Article

Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis CMORISHIMA, Chihiro; SHIFFMAN, Mitchell L; MORGAN, Timothy R et al.The American journal of gastroenterology. 2012, Vol 107, Num 9, pp 1388-1398, issn 0002-9270, 11 p.Article

High Sustained Virologic Response Rates in Rapid Virologic Response Patients in the Large Real-World PROPHESYS Cohort Confirm Results From Randomized Clinical TrialsMARCELLIN, Patrick; CHEINQUER, Hugo; PUOTI, Massimo et al.Hepatology (Baltimore, Md.). 2012, Vol 56, Num 6, pp 2039-2050, issn 0270-9139, 12 p.Article